Sanofi says Zaltrap approved in Europe for colorectal cancer

PARIS (Reuters) - French drugmaker Sanofi said on Tuesday that its Zaltrap drug had been approved for marketing in the European Union to treat metastatic colorectal cancer.

via Reuters: Health News Read More Here..